Accéder au contenu
Merck

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

Bioorganic & medicinal chemistry letters (2010-04-07)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Philip J Skinner, Jae-Kyu Jung, Jerry Xu, Martin C Cherrier, Peter J Webb, Graeme Semple, Carleton R Sage, Jens Knudsen, Ruoping Chen, Andrew K Taggart, Ester Carballo-Jane, Jeremy G Richman
RÉSUMÉ

Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Acide nicotinique, ≥99.5% (HPLC)
Sigma-Aldrich
Acide nicotinique, ≥98%
Sigma-Aldrich
Acide nicotinique, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Supelco
Acide nicotinique, analytical standard
Sigma-Aldrich
Acide nicotinique, meets USP testing specifications